Risperidone Safety and Efficacy in the Treatment of Bipolar and Schizoaffective Disorders

Authors:
  • JGJose M. Goikolea
    Jose M. Goikolea
  • BCBarbara Corbella
    Barbara Corbella
  • ABAntonio Benabarre
    Antonio Benabarre
  • GMGuadalupe Martìnez
    Guadalupe Martìnez
  • AFAntonio Fernandez
    Antonio Fernandez
  • AMAnabel Martinez-Aran
    Anabel Martinez-Aran
  • C(Carla Torrent for the Group for the Study of Risperidone in Affective Disorders (GSRAD)
    Carla Torrent for the Group for the Study of Risperidone in Affective Disorders (GSRAD)

Abstract
No abstract available